Prevalence of human papillomavirus infection in women in Busan, South Korea

被引:112
作者
Shin, HR
Lee, DH
Herrero, R
Smith, JS
Vaccarella, S
Hong, SH
Jung, KY
Kim, HH
Park, UD
Cha, HS
Park, S
Touzé, A
Muñoz, N
Snijders, PJF
Meijer, CJLM
Coursaget, P
Franceschi, S
机构
[1] Int Agcy Res Canc, Unit Field & Intervent Studies, F-69372 Lyon 08, France
[2] Natl Canc Ctr, Res Inst, Div Canc Epidemiol & Control, Goyang, South Korea
[3] Kosin Univ, Pusan, South Korea
[4] Proyecto Epidemiol Guanacaste, San Jose, Costa Rica
[5] Dong A Univ, Pusan, South Korea
[6] Catholic Univ, Taegu, South Korea
[7] Univ Tours, INSERM, EMIU 00 10, Mol Virol Lab, Tours, France
[8] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
关键词
human papillomavirus; HPV DNA; HPVVLP antibodies; Korea; prevalence; risk factors;
D O I
10.1002/ijc.10825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the prevalence of and the risk factors for human papillomavirus (HPV) infection in South Korea, we interviewed and examined a randomly selected sample of 863 sexually active women (age range=20-74 years, median 44) and 103 self-reported virgins from Busan. The presence of DNA of 34 different HPV types in cervical exfoliated cells was tested among sexually active women by means of a PCR-based assay. IgG antibodies against L1 virus-like particles (anti-VLPs) of HPV types 16, 18, 31, 33 and 58 were also evaluated by means of ELISA. The overall prevalence of HPV DNA was 10.4% (95% confidence interval, CI: 83-12.7%). The most often found HPV DNA types were HPV 70, HPV 16 and HPV 33; 19.8% (95% CI: 17.2-22.0) of sexually active women had antibodies against one or more HPV types. The most common anti-VLPs were against HPV 18, 31 and 16. Prevalences standardized by age on the basis of the world standard population were 13.0% for HPV DNA and 17.1% for anti-VLPs. The concordance between the 2 HPV markers at an individual level was modest, but the risk factors for detection of HPV DNA and anti-VLPs were similar: number of lifetime sexual partners (odds ratio, OR for greater than or equal to4 vs. I=3.5 and 5.4, respectively), seropositivity for herpes simplex virus-2 antibodies (OR=2.6 and 2.5, respectively) and being single or divorced. HPV DNA, but not anti-VLPs, were elevated among women whose husbands were thought by their wives to have extra-marital affairs and those who had undergone vasectomy. Among 103 virgins, 4.9% had anti-VLPs (1/73 among those aged 24 years or less). (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:413 / 421
页数:9
相关论文
共 47 条
[1]  
ANH PTH, 2002, IN PRESS BR J CANC
[2]   Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain [J].
Bosch, FX ;
Castellsague, X ;
Munoz, N ;
deSanjose, S ;
Ghaffari, AM ;
Gonzalez, LC ;
Gili, M ;
Izarzugaza, I ;
Viladiu, P ;
Navarro, C ;
Vergara, A ;
Ascunce, N ;
Guerrero, E ;
Shah, KV .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (15) :1060-1067
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]   The causal relation between human papillomavirus and cervical cancer [J].
Bosch, FX ;
Lorincz, A ;
Muñoz, N ;
Meijer, CJLM ;
Shah, KV .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265
[5]   Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection [J].
Carter, JJ ;
Koutsky, LA ;
Hughes, JP ;
Lee, SK ;
Kuypers, J ;
Kiviat, N ;
Galloway, DA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :1911-1919
[6]   Human papillomavirus genotypes in rural Mozambique [J].
Castellsagué, X ;
Menéndez, C ;
Loscertales, MP ;
Kornegay, JR ;
dos Santos, F ;
Gómez-Olivé, FX ;
Lloveras, B ;
Abarca, N ;
Vaz, N ;
Barreto, A ;
Bosch, FX ;
Alonso, P .
LANCET, 2001, 358 (9291) :1429-1430
[7]  
CLIFFORD GM, IN PRESS BR J CANC
[8]   Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer [J].
Combita, AL ;
Bravo, MM ;
Touzé, A ;
Orozco, O ;
Coursaget, P .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) :796-803
[9]   Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses [J].
Combita, AL ;
Touzé, A ;
Bousarghin, L ;
Christensen, ND ;
Coursaget, P .
JOURNAL OF VIROLOGY, 2002, 76 (13) :6480-6486
[10]  
Coursaget P, 1999, CANCER SURV, V33, P355